Clinical results of the use of preoperative portal occlusion in the surgical treatment of hepatic metastases;Resultados clínicos de la utilización de la oclusión portal preoperatoria en el tratamiento quirúrgico de las metástasis hepáticas

Cirugia Espanola

Volumn 70, Issue 3, 2001, Pages 152-156

  Lopez Ben S ^a   Figueras, J ^a   Lama, C ^a   Busquets, J ^a   Dominguez J ^a   Sancho, C ^a   Escalante, E ^a   Canas C ^a   Miquel, A ^a   Valls, C ^a   Rafecas, A ^a   Torras, J ^a   Ramos, E ^a   Jaurrieta, E ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Embolization; Liver neoplasm; Liver regeneration; Portal Vein; Therapeutic

Indexed keywords

EID: 8844278486     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(01)71866-0     Document Type: Article

References (23)

1. Makuuchi M, Le Thai B, Takayasu K, Takayama T, Kosuge T, Gunvén P et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery 1990; 107: 521-527.
2. Elias D, Roche A, Vavasseur D, Lasser P. Induction d'une hypertrophie d'un petit lobe gauche hepatique avant hepatectomie droite elargie, par embolisation portale droit pre-operative. Annales de Chirurgie 1992; 46: 404-410.
3. Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg 1993; 17: 109-115.
4. Rous P, Larimore LD. Relation of the portal blood to liver maintenance. J Exp Med 1920; 31: 609-632.
5. Schalm L, Bax HR, Mansens J. Atrophy of the liver after oclusion of the bile ducts of portal vein and compensatory hypertrophy of the unoccluded portion and his clinical importance. Gastroenterology 1956; 31: 131-155.
6. Honjio I, Suzuki T, Ozawa K, Takasan H, Kitamura O, Ishikawa T. Ligation of a branch of the portal vein for carcinoma of the liver. Am J Surg 1975; 130: 296-302.
7. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986; 10: 803-808.
8. Kosuge T, Makuuchi M, Takayama T, Shimada K, Yamamoto J, Yamazaki S et al. Preoperative portal embolization increases safety of hepatectomy. Nippon Geka Gakkai Zasshi 1991; 92: 1320-1323.
9. Elias D, De Baere T, Roche A, Bonvallot S, Lasser P. Preoperative selective portal vein embolizations are an effective means of extending the indications of major hepatectomy in the normal and injured liver. Hepatogastroenterology 1998; 45: 170-177.
10. Kawasaki S, Makuuchi M, Kazazu T, Miyagawa S, Takayama T, Kosuge T et al. Resection for multiple metastasic liver tumors after portal embolization. Surgery 1994; 115: 674-677.
11. Shimamura T, Nakajima Y, Une Y, Namieno T, Ogasawara K, Yamashita K et al. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery 1997; 121: 135-141.
12. Takayama T, Makuuchi M, Kosuge T, Yamamoto J, Shimada K, Inoue K. Preoperative portal embolization. Annali Italiani di Chirurgia 1997; 68: 745-750.
13. De Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 1996; 24: 1386-1391.
14. Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M. Selective transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 1996; 200: 559-563.
15. Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa SI et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 1999; 29: 1099-1105.
16. Elias D, De Baere T, Roche A, Ducreux M, Leelere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999; 86: 784-788.
17. Bilodeau M, Ethier C, Houle R, Rocheleau B, Liver atrophy induced by graded stenosis of the left portal vein (PV) is highly correlated with the amount of apoptotic cell death. Hepatology 1996; 24: 484A.
18. Harada H, Imamura H, Miyagawa S, Kawasaki S. Fate of human liver after hemihepatic portal vein embolization: cell kinetic and morphometric study. Hepatology 1997; 26: 1162-1170.
19. Starzl TE, Francavilla A, Halgrimson CG, Francavilla FR, Porter KA, Brown TH et al. The origin, hormonal nature, and action of hepatotropic substances in portal venous blood. Surg Ginecol Obstet 1973; 173: 179-199.
20. Hadjis NS, Schweizer W, Blumgart LH. Liver hiperplasia, hypertrophy and atrophy: clinical relevance. En: Blumgart LH, editor. Surgery of the liver and biliary tract. Edimburgo: Churchill Livingstone, 1994; 83-92.
21. Kaido T, Yoshikawa A, Seto S, Ishii T, Inoue K, Imamura M. Hepatocyte growth factor supply accelerates compensatory caused by portal branch ligation in normal and jaundiced rats. J Surg Res 1999; 85: 115-119.
22. Takada T, Ammori BJ, Yoshida M, Amano H, Yasuda H, Takeshita K et al. Combined preoperatory embolization of the right portal vein and hepatic artery for hepatic resection in a high-risk patient. AJR 1999; 173: 165-167.
23. Akasu T, Moriya Y, Takayama T. A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after infusion chemotherapy and portal embolization. Japanese.